BR112021018930A2 - Miriquizumabe para uso em um método de tratamento de doença de crohn - Google Patents
Miriquizumabe para uso em um método de tratamento de doença de crohnInfo
- Publication number
- BR112021018930A2 BR112021018930A2 BR112021018930A BR112021018930A BR112021018930A2 BR 112021018930 A2 BR112021018930 A2 BR 112021018930A2 BR 112021018930 A BR112021018930 A BR 112021018930A BR 112021018930 A BR112021018930 A BR 112021018930A BR 112021018930 A2 BR112021018930 A2 BR 112021018930A2
- Authority
- BR
- Brazil
- Prior art keywords
- disease
- miriquizumab
- treating crohn
- crohn
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
- A61K39/3955—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against proteinaceous materials, e.g. enzymes, hormones, lymphokines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/244—Interleukins [IL]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biochemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Endocrinology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Saccharide Compounds (AREA)
Abstract
miriquizumabe para uso em um método de tratamento de doença de crohn. a presente invenção refere-se, de modo geral, ao tratamento de doença de crohn com um anticorpo anti-il-23p19, particularmente regimes de dosagem para o tratamento da doença.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962836910P | 2019-04-22 | 2019-04-22 | |
| PCT/US2020/028273 WO2020219314A1 (en) | 2019-04-22 | 2020-04-15 | Mirikizumab for use in a method of treating crohn's disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112021018930A2 true BR112021018930A2 (pt) | 2022-01-18 |
Family
ID=70554215
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112021018930A BR112021018930A2 (pt) | 2019-04-22 | 2020-04-15 | Miriquizumabe para uso em um método de tratamento de doença de crohn |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20220040299A1 (pt) |
| EP (1) | EP3958897A1 (pt) |
| JP (2) | JP7297930B2 (pt) |
| KR (1) | KR20210142704A (pt) |
| CN (1) | CN113677366A (pt) |
| AU (2) | AU2020263238C1 (pt) |
| BR (1) | BR112021018930A2 (pt) |
| CA (1) | CA3134587A1 (pt) |
| EA (1) | EA202192532A1 (pt) |
| IL (1) | IL286818A (pt) |
| MA (1) | MA55756A (pt) |
| MX (1) | MX2021012848A (pt) |
| SG (1) | SG11202110619XA (pt) |
| TW (1) | TW202103734A (pt) |
| WO (1) | WO2020219314A1 (pt) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20220066831A (ko) | 2020-11-16 | 2022-05-24 | 엔브이에이치코리아(주) | 습기경화형 접착제를 이용한 헤드라이닝 제조방법 및 이에 의해 제조되는 헤드라이닝 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JOP20140049B1 (ar) | 2013-03-08 | 2021-08-17 | Lilly Co Eli | أجسام مضادة ترتبط بـ il-23 |
| NZ712294A (en) | 2013-03-15 | 2020-04-24 | Amgen Inc | Methods for treating crohn’s disease using an anti-il23 antibody |
| TWI733695B (zh) | 2015-09-18 | 2021-07-21 | 德商百靈佳殷格翰國際股份有限公司 | 治療發炎性疾病之方法 |
| MX2020000186A (es) * | 2017-07-10 | 2021-01-29 | Rambam Med Tech Ltd | Ensayos para evaluar los niveles de anticuerpos neutralizantes en sujetos tratados con un fármaco biológico y usos de los mismos en medicina personalizada. |
-
2020
- 2020-04-14 TW TW109112447A patent/TW202103734A/zh unknown
- 2020-04-15 MX MX2021012848A patent/MX2021012848A/es unknown
- 2020-04-15 WO PCT/US2020/028273 patent/WO2020219314A1/en unknown
- 2020-04-15 SG SG11202110619XA patent/SG11202110619XA/en unknown
- 2020-04-15 CA CA3134587A patent/CA3134587A1/en active Pending
- 2020-04-15 BR BR112021018930A patent/BR112021018930A2/pt unknown
- 2020-04-15 EA EA202192532A patent/EA202192532A1/ru unknown
- 2020-04-15 AU AU2020263238A patent/AU2020263238C1/en active Active
- 2020-04-15 JP JP2021562882A patent/JP7297930B2/ja active Active
- 2020-04-15 EP EP20724301.5A patent/EP3958897A1/en active Pending
- 2020-04-15 KR KR1020217034113A patent/KR20210142704A/ko not_active Application Discontinuation
- 2020-04-15 CN CN202080030747.5A patent/CN113677366A/zh active Pending
- 2020-04-15 MA MA055756A patent/MA55756A/fr unknown
-
2021
- 2021-09-29 IL IL286818A patent/IL286818A/en unknown
- 2021-10-21 US US17/507,414 patent/US20220040299A1/en active Pending
-
2023
- 2023-06-14 JP JP2023097427A patent/JP2023116680A/ja active Pending
- 2023-11-13 AU AU2023265759A patent/AU2023265759A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CA3134587A1 (en) | 2020-10-29 |
| IL286818A (en) | 2021-10-31 |
| MX2021012848A (es) | 2021-12-10 |
| EP3958897A1 (en) | 2022-03-02 |
| CN113677366A (zh) | 2021-11-19 |
| EA202192532A1 (ru) | 2022-01-21 |
| AU2020263238B2 (en) | 2023-08-17 |
| AU2020263238C1 (en) | 2024-02-22 |
| WO2020219314A1 (en) | 2020-10-29 |
| JP7297930B2 (ja) | 2023-06-26 |
| SG11202110619XA (en) | 2021-11-29 |
| JP2023116680A (ja) | 2023-08-22 |
| KR20210142704A (ko) | 2021-11-25 |
| TW202103734A (zh) | 2021-02-01 |
| JP2022530397A (ja) | 2022-06-29 |
| AU2023265759A1 (en) | 2023-12-07 |
| US20220040299A1 (en) | 2022-02-10 |
| AU2020263238A1 (en) | 2021-11-04 |
| MA55756A (fr) | 2022-03-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112018008358A2 (pt) | ?composições e métodos para terapia relacionada à microbiota fecal? | |
| BR112018003984A2 (pt) | anticorpos | |
| BR112015025803A2 (pt) | método para tratar um substrato animal | |
| BR112018003985A2 (pt) | macrociclos peptidomiméticos e usos dos mesmos | |
| BR112016025009A2 (pt) | anticorpos humanos para a síndrome respiratória do oriente médio - proteína de superfície | |
| BR112017023576A2 (pt) | Método para tratar uma disfunção proliferativa de células b | |
| BR112016005816A2 (pt) | Combinação de anticorpos anti-lag-3 e anticorpos anti-pd-1 para tratar tumores | |
| BR112018072560A2 (pt) | terapia de combinação para tratamento do câncer | |
| EA202190708A1 (ru) | Модуляторы экспрессии pnpla3 | |
| BR112016004415A2 (pt) | método de tratamento de um paciente diagnosticado com um glioblastoma, uso de uma quantidade eficaz de um anticorpo anti-vegf, composição e kit | |
| BR112018068512A2 (pt) | métodos para tratar câncer de mama er+, her2-, hrg+ com o uso de terapias de combinação que compreendem um anticorpo anti-erbb3 | |
| EA202090061A1 (ru) | Применение антитела против cd70, argx-110, для лечения острого миелоидного лейкоза | |
| EA201792545A1 (ru) | Способы и наборы для лечения депрессии | |
| BR112015030356A2 (pt) | métodos de tratamento de uma taupatia | |
| BR112021011684A2 (pt) | Terapia combinada com cd70 e venetoclax, um inibidor de bcl-2, para o tratamento da leucemia mieloide aguda | |
| BR112019022280A2 (pt) | tratamento de cânceres de her2 positivo | |
| MX2020009879A (es) | Anticuerpos anti-il-27 y sus usos. | |
| BR112015027474A8 (pt) | anticorpo, composição, método de tratamento do paciente que sofre de câncer e uso de um anticorpo. | |
| MX2019001958A (es) | Metodos para tratar la enfermedad de crohn con un anticuerpo anti-nkg2d. | |
| BR112019005040A2 (pt) | aplicação de pridopidina para tratamento de síndrome de rett | |
| MX2021006980A (es) | Anticuerpos anti-il-27 y usos de estos. | |
| BR112018014467A2 (pt) | tecnologia de sinergismo fármaco-anticorpo para o tratamento de doenças | |
| BR112019008241A2 (pt) | tratamento do prurigo nodular | |
| BR112015031950A2 (pt) | métodos para tratamento de câncer de ovário | |
| BR112021017550A2 (pt) | Métodos de tratamento da amiloidose al |